BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND TG, Thyroglobulin AND Treatment
46 results:

  • 1. Mucin-1-Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid tumors in Immunocompetent Host.
    Zhou R; Wu ST; Yazdanifar M; Williams C; Sanders A; Brouwer C; Maher J; Mukherjee P
    J Immunother; 2024 Apr; 47(3):77-88. PubMed ID: 38270462
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Evaluation of the Carcinogenic Potential of Enarodustat (JTZ-951), a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor, in 26-Week Tg.rasH2 Mouse Study and 2-Year Sprague-Dawley Rat Study.
    Kemmochi Y; Toyoda K; Ishida T; Yasui Y; Shoda T
    Int J Toxicol; 2023 Dec; 42(6):489-503. PubMed ID: 37480334
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clear evidence of the carcinogenic potential of anthracene: A 2-year feeding study in rats and mice.
    Takeda T; Suzuki M; Kano H; Matsumoto M; Umeda Y
    Environ Toxicol; 2023 Mar; 38(4):709-726. PubMed ID: 36478108
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans.
    Ma Y; Joyce A; Brandenburg O; Saatchi F; Stevens C; Toffessi Tcheuyap V; Christie A; Do QN; Fatunde O; Macchiaroli A; Wong SC; Woolford L; Yousuf Q; Miyata J; Carrillo D; Onabolu O; McKenzie T; Mishra A; Hardy T; He W; Li D; Ivanishev A; Zhang Q; Pedrosa I; Kapur P; Schluep T; Kanner SB; Hamilton J; Brugarolas J
    Clin Cancer Res; 2022 Dec; 28(24):5405-5418. PubMed ID: 36190432
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma.
    Mulgaonkar A; Elias R; Woolford L; Guan B; Nham K; Kapur P; Christie A; Tcheuyap VT; Singla N; Bowman IA; Stevens C; Hao G; Brugarolas J; Sun X
    Clin Cancer Res; 2022 Nov; 28(22):4907-4916. PubMed ID: 36074149
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A Randomized Study on the Effect of Metformin Combined with Intensive-Exercise Diet Therapy on Glucose and Lipid Metabolism and Islet Function in Patients with Renal Cell Carcinoma and Diabetes.
    Liu Y; Meng LL; Li JW; Jin YS; An RH
    Dis Markers; 2022; 2022():7383745. PubMed ID: 35872697
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Membranous Nephropathy Secondary to Graves' Disease: A Case Report.
    Neves PDMM; Muniz MPR; Morgantetti GF; Cutrim ÉMM; Macieira CA; Salgado-Filho N; Lages JS; Brito DJA; Cunha KA; Gatto GC; Silva GEB
    Front Immunol; 2022; 13():824124. PubMed ID: 35734176
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A renal cell carcinoma tumorgraft platform to advance precision medicine.
    Elias R; Tcheuyap VT; Kaushik AK; Singla N; Gao M; Reig Torras O; Christie A; Mulgaonkar A; Woolford L; Stevens C; Kettimuthu KP; Pavia-Jimenez A; Boroughs LK; Joyce A; Dakanali M; Notgrass H; Margulis V; Cadeddu JA; Pedrosa I; Williams NS; Sun X; DeBerardinis RJ; Öz OK; Zhong H; Seshagiri S; Modrusan Z; Cantarel BL; Kapur P; Brugarolas J
    Cell Rep; 2021 Nov; 37(8):110055. PubMed ID: 34818533
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics.
    Li W; Wang X; Zhang X; Gong P; Ding D; Wang N; Wang Z
    Lipids Health Dis; 2021 Nov; 20(1):160. PubMed ID: 34774030
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma.
    Gubbi S; Al-Jundi M; Del Rivero J; Jha A; Knue M; Zou J; Turkbey B; Carrasquillo JA; Lin E; Pacak K; Klubo-Gwiezdzinska J; Lin FI
    Front Endocrinol (Lausanne); 2020; 11():587065. PubMed ID: 33551992
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Unusual metastases from differentiated thyroid cancers: A multicenter study in Korea.
    Yoon JH; Jeon MJ; Kim M; Hong AR; Kim HK; Shin DY; Kim BH; Kim WB; Shong YK; Kang HC
    PLoS One; 2020; 15(8):e0238207. PubMed ID: 32841270
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients.
    Basak EA; van der Meer JWM; Hurkmans DP; Schreurs MWJ; Oomen-de Hoop E; van der Veldt AAM; Bins S; Joosse A; Koolen SLW; Debets R; Peeters RP; Aerts JGJV; Mathijssen RHJ; Medici M
    Thyroid; 2020 Jul; 30(7):966-973. PubMed ID: 32151195
    [No Abstract]    [Full Text] [Related]  

  • 13. Persistent Elevation of thyroglobulin in Patient Treated for Differentiated Thyroid Cancer: A Ten-Year Review.
    Khan S; Prabhushankar R; Leary E; Khan UZ
    Mo Med; 2017; 114(5):387-393. PubMed ID: 30228641
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Changing Trend of thyroglobulin Antibodies in Patients With Differentiated Thyroid Cancer Treated With Total Thyroidectomy Without
    Matrone A; Latrofa F; Torregrossa L; Piaggi P; Gambale C; Faranda A; Ricci D; Agate L; Molinaro E; Basolo F; Vitti P; Elisei R
    Thyroid; 2018 Jul; 28(7):871-879. PubMed ID: 29860933
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Thyroid follicular carcinoma-like renal tumor: A case report and literature review.
    Zhang Y; Yang J; Zhang M; Meng Z; Song W; Yang L; Li L; Wang D; Shi T
    Medicine (Baltimore); 2018 May; 97(21):e10815. PubMed ID: 29794767
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Germline Genetic Biomarkers of Sunitinib Efficacy in Advanced Renal Cell Carcinoma: Results From the RENAL EFFECT Trial.
    Motzer RJ; Figlin RA; Martini JF; Hariharan S; Agarwal N; Li CX; Williams JA; Hutson TE
    Clin Genitourin Cancer; 2017 Oct; 15(5):526-533. PubMed ID: 28330808
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Twenty-six-week oral carcinogenicity study of 3-monochloropropane-1,2-diol in CB6F1-rasH2 transgenic mice.
    Lee BS; Park SJ; Kim YB; Han JS; Jeong EJ; Son HY; Moon KS
    Arch Toxicol; 2017 Jan; 91(1):453-464. PubMed ID: 27017489
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Thyroid-like follicular carcinoma of the kidney: one case report and review of the literature.
    Dawane R; Grindstaff A; Parwani AV; Brock T; White WM; Nodit L
    Am J Clin Pathol; 2015 Nov; 144(5):796-804. PubMed ID: 26486745
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Follicular Variant of Papillary Thyroid Cancer with Bilateral Renal Metastases Discovered Incidentally During Work-Up of Primary Endometrial Cancer: A Rare Occurrence.
    Lubana SS; Singh N; Tuli SS; Bashir T; Sachmechi I; Kemeny MM
    Am J Case Rep; 2015 Jul; 16():459-68. PubMed ID: 26181765
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Metastatic follicular thyroid carcinoma masquerading as olfactory neuroblastoma: with skull-base, cranium, paranasal sinus, lung, and diffuse bone metastases.
    Altinay S; Taşkin Ü; Aydin S; Oktay MF; Özen A; Ergül N
    J Craniofac Surg; 2015 Jan; 26(1):e3-6. PubMed ID: 25569410
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.